Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy-Reference-Cited by-同舟云学术

Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy

Published:2017-08-23 Issue:11 Volume:54 Page:771-780
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Heo Sun Hee,Kang Eungu,Kim Yoon-Myung,Go Heounjeong,Kim Kyung Yong,Jung Jae Yong,Kang Minji,Kim Gu-Hwan,Kim Jae-Min,Choi In-Hee,Choi Jin-Ho,Jung Sung-Chul,Desnick Robert J,Yoo Han-Wook,Lee Beom Hee^ORCID

Funder

National Research Foundation of Korea

Publisher

BMJ

Subject

Genetics (clinical),Genetics

Reference46 articles.

1. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells;Shen;Mol Genet Metab,2008

2. Leukocyte perturbation associated with Fabry disease;Rozenfeld;J Inherit Metab Dis,2009

3. Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings;Cigna;Mol Biosyst,2013

4. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease;Eng;N Engl J Med,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes;Cells;2024-07-06

2. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers;Translational Research;2024-07

3. Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications;Frontiers in Cardiovascular Medicine;2024-06-12

4. Neuraminidase 1 regulates the cellular state of microglia by modulating the sialylation of Trem2;2024-05-20

5. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?;Rare Disease and Orphan Drugs Journal;2024-04-25